
Woman Visits Gym Every Week, but There's a Twist: 'Need This'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
A savvy woman has shared the only reason she goes to the gym once a week—and it isn't to work out.
The TikTok clip, shared by @almillishit, has gathered 4.6 million views and 316,400 likes. It shows a spray tan machine, and the text overlaid explains that she pays $25 a month for a fitness membership "just to get a weekly spray and never actually work out."
The Delaware-based woman told another user: "I'm genuinely so lucky [and] grateful."
Some users expressed their envy, and said: "So jealous. Mine only has tanning booths!!!"
Many users are impressed with the woman's money-saving hack, as the average cost of a spray tan is generally between $25 and $60, according to The Knot.
"That's cheaper than the tanning bed I pay for at the salon each month," said one user, and another wrote: "Damn. I just paid $40 for one level 1 spray tan."
"This should be it instead of the tanning beds," suggested a third user.
In the comments, the woman tells another user that she is "scared" of sunbeds, most likely because sunlamps and sunbeds—including tanning beds and booths—are classified as known human carcinogens.
A stock image of women using her phone in a gym.
A stock image of women using her phone in a gym.
Oscar Gutierrez Zozulia/iStock / Getty Images Plus
Are Spray Tans Safe?
According to the American Cancer Society, the amount and type of ultraviolet (UV) radiation a person receives from tanning beds depend on several factors: the type of lamps used, the duration of exposure, and the frequency of use. Most tanning beds primarily emit UVA rays, with a smaller proportion being UVB, which is a risk factor for all types of skin cancer.
As a safer alternative, many people opt for sunless tanning methods such as fake tan products or sprays. These products work by interacting with proteins on the surface of the skin to create a temporary darkening effect, mimicking a natural tan. Like a real tan, the color gradually fades over several days.
Most sunless tanning products contain an FDA-approved ingredient called dihydroxyacetone (DHA), a color additive used specifically for external application.
When used correctly, these products are generally considered safe. However, the American Cancer Society cautions that DHA should only be used on the skin's surface and not:
Inhaled through the nose or mouth.
Ingested.
Applied to areas with mucous membranes (such as the eyes, nose, or lips).
If you're considering using a sunless tanning product, consult your doctor—especially if you have sensitive skin or health concerns. It's also important to note that most of these products do not provide sun protection.
Even if a product contains sunscreen, its effectiveness typically lasts only a few hours.
To reduce the risk of skin damage and skin cancer, continue using broad-spectrum sunscreen and wearing protective clothing when spending time outdoors.
Newsweek has reached out to @almillishit for comment via email. We could not verify the details of the case.
Do you have any clever hacks you use to make life easier (or cheaper) that you want to share? Send them to life@newsweek.com with some details and they could appear in our Pet of the Week lineup.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
8 minutes ago
- CBS News
RFK Jr. taps allies and COVID vaccine critics among picks for CDC advisory panel. Here's who's on the list.
Health and Human Services Robert F. Kennedy Jr. announced Wednesday he's naming eight new advisers to serve on the Centers for Disease Control and Prevention's vaccine recommendations committee, after firing the committee's entire previous roster of 17 advisers. "All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense. They have each committed to demanding definitive safety and efficacy data before making any new vaccine recommendations," Kennedy said Wednesday in a post on X. Kennedy's picks circumvented the usual CDC process for selecting members of the Advisory Committee on Immunization Practices. In previous administrations, career agency officials — not political leaders — vetted potential experts before forwarding them to the department for the secretary's approval. The panel's influential recommendations are closely watched because they are directly tied to federal policies, like which vaccines insurers are required to cover. The picks announced by Kennedy include some close allies of the secretary and his inner circle. One of them, Dr. Robert Malone, worked on early research related to mRNA vaccine technology but was accused during the COVID-19 pandemic of spreading misinformation about the mRNA vaccines. He was with Kennedy and President Trump at the Trump election night celebration in Florida. "On the basis of data from all over the world, approximately three years ago it was my impression that the risk/benefit ratio of these products did not merit continued use in any cohort," Malone posted last month on his Substack about the mRNA COVID vaccines. Like Kennedy, Malone has questioned the benefits of measles vaccines during the recent record outbreak in Texas, which killed two children, and he has promoted unproven treatments for the virus. Another member picked by Kennedy is Dr. Martin Kulldorff, an epidemiologist who co-authored the pandemic-era Great Barrington Declaration criticizing COVID-19 restrictions, along with now-NIH Director Dr. Jay Bhattacharya. Bhattacharya has described Kulldorff as a close friend. Kulldorff previously worked with the CDC's outside vaccine advisers, before authoring an opinion piece in 2021 criticizing the agency's decision to pause use of Johnson & Johnson's COVID-19 vaccine over safety concerns. He claimed he was fired from working with the committee over the opinion piece. Kulldorff later claimed he was fired from Harvard University for criticizing COVID-19 vaccine requirements. Dr. Cody Meissner, a pediatrics professor who previously served as a member of the Food and Drug Administration's own vaccines panel — the Vaccines and Related Biological Products Advisory Committee – was also named to the committee. Meissner opposed COVID-19 vaccine requirements for children. He also co-authored an opinion piece with now-FDA Commissioner Dr. Marty Makary speaking out against masking of children during the pandemic. Another former member of the FDA vaccines panel who was picked by Kennedy is Vicky Pebsworth, a regional director of the National Association of Catholic Nurses. Pebsworth spoke at a 2020 meeting of the FDA vaccines committee, where she identified herself as the research director for the National Vaccine Information Center and "mother of a child injured by his 15-month well-baby shots in 1998." She said the center's position was that any "coercion and sanctions to persuade adults to take an experimental vaccine, or give it to their children, is unethical and unlawful." Kennedy also praised another pick, MIT professor Retsef Levi, saying: "Dr. Levi has collaborated with public health agencies to evaluate vaccine safety, including co-authoring studies on mRNA COVID-19 vaccines and their association with cardiovascular risks." Levi previously called for more detailed data from the COVID-19 vaccine trials, suggesting that changes to how Pfizer's shot was produced may have caused side effects. But Levi faced criticism for a paper co-authored with Florida Surgeon General Dr. Joseph Ladapo, which was cited in the state's move to recommend that young men not get mRNA COVID-19 vaccines. Experts condemned the paper for misleading methods that could inflate the risk. The views on vaccines of several of Kennedy's other picks are less clear. Kennedy said Dr. Michael A. Ross "contributed to national strategies for cancer prevention and early detection, including those involving HPV immunization," working with the CDC's breast and cervical cancer committee. Ross is described by Kennedy as an obstetrics and gynecology professor at George Washington University and Virginia Commonwealth University, though his name does not appear on directories for either university. Spokespeople for the two institutions did not immediately respond to a request for comment. Dr. James Pagano, described by Kennedy as a "strong advocate for evidence-based medicine," appears to have published little about vaccines or medicine. Records from the Medical Board of California list Pagano as being retired. Another Kennedy pick, Dr. Joseph Hibbeln, retired from the National Institutes of Health in 2020. His research portfolio previously covered nutritional intake of fatty acids like omega-3. Kennedy described him as bringing "expertise in immune-related outcomes, psychiatric conditions, and evidence-based public health strategies."


Newsweek
25 minutes ago
- Newsweek
Long-Term Use of This Contraceptive Pill Linked to Increased Brain Tumor Risk
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Using the progestogen-only contractive pill "desogestrel" for more than five years may increase the risk of developing a type of brain tumor known as an "intracranial meningioma," a new study has warned. The researchers noted that the risk is low—and is eliminated one year after desogestrel treatment is suspended—but that doctors' awareness of the possibility could eliminate the need for surgery in some cases. Meningiomas are a rare, non-cancerous form of tumor that arise from the membranes surrounding the brain. While slow-growing and benign in and of themselves, they can develop to a size that compresses other structures in the brain. They usually only require surgery when they cause symptoms such as persistent headaches or neurological issues. Woman holding combined oral contraceptive pill. Woman holding combined oral contraceptive pill. PATCHARIN SIMALHEK The study, based on data from France's national health system, compared over 8,000 women who underwent surgery for meningioma between 2020 and 2023 with more than 83,000 matched controls. Researchers found that women who had taken desogestrel continuously for more than five years had a slightly elevated risk of developing the brain tumors. Reassuringly, no increased risk was found for short-term use or for other commonly used progestogens like levonorgestrel, either alone or combined with estrogen. "This large study using French national database... shows [an] association between taking a certain progestogen (desogestrel) continuously for more than five years and meningioma risk, however, the magnitude of increase in the risk is small," said paper author Dr. Mangesh Thorat of Queen Mary University of London in a statement. Short-term use does not increase risk and the risk ceases after stopping use, he added. The authors estimate that one woman in every 67,000 using desogestrel would need surgery for meningioma and this drops to 1 in 17,000 with continuous use beyond five years. By comparison, breast cancer is about 10 times more common than meningioma. To understand progestogens, Thorat said it's crucial to note that the effects of different drug formulations can vary significantly and individual drugs can affect various organs differently. "Therefore, it is important to consider which specific drug is being used by an individual," he said. The study also showed that Microgynon and the morning-after pill—both containing levonorgestrel—were not linked to increased risk. Still, the findings have clinical relevance, especially for women over 45 or those with a prior history of using other high-risk progestogens. In such cases, the study suggests discontinuing desogestrel if a meningioma is identified, rather than jumping straight to surgery. "Stopping desogestrel may also avoid unnecessary potentially harmful treatments," said neurosurgeon Gilles Reuter of the University Hospital Liegein an accompanying editorial. Reuter emphasized that similar results have already been seen with other high-risk progestogens. While the study is observational and cannot prove cause and effect, its large sample size adds weight to the findings. However, experts say the takeaway should be caution, not alarm. For those affected by the findings, Thorat advises speaking with a healthcare provider regarding which drug is being used. "If it is associated with an increased risk of meningioma, this can be changed to a safer alternative," he said. "There is no reason to panic as the risk is very small and even in those who developed meningioma, stopping the specific drug has shown to cause regression in the size of meningioma." Do you have a tip on a health story that Newsweek should be covering? Do you have a question about contraceptives? Let us know via health@ References Roland, N., Kolla, E., Baricault, B., Dayani, P., Duranteau, L., Froelich, S., Zureik, M., & Weill, A. (2025). Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial meningioma: National case-control study. BMJ, 389. Reuter, G. (2025). Progestogens and meningioma: New evidence on levonorgestrel and desogestrel. BMJ, 389.


Newsweek
36 minutes ago
- Newsweek
Mushroom Recall Sparks Nationwide Warning to Customers
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Hofood99 Inc. is recalling packages of their Enoki Mushrooms due to fears the product may be contaminated with listeria. Newsweek reached out to the company via phone for additional comment on Wednesday and left a voicemail. Why It Matters Numerous recalls have been initiated this year due to the potential for the following: damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or food allergies every year. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. The FDA warns that Listeria monocytogenes is an organism that could cause serious and sometimes fatal infections in frail or older people, young children and those with weakened immune systems. Listeria could also lead to stillbirths or miscarriages in pregnant women, the FDA says. What To Know According to the FDA alert, the mushrooms were distributed nationwide to stores and retailers. The recalled mushrooms are sold in 200-gram green plastic packaging with a with UPC Barcode of 6 976532 310051 seen on the back label. No illnesses or injuries have been reported related to the recalled mushrooms. The mushrooms were distributed by Hofood99 Inc., located at 21903 56th Avenue Oakland Gardens, New York 11364. Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) What People Are Saying The FDA in the alert in part: "The contamination was discovered after samples were collected from a store in Michigan and subsequent analysis by Michigan Department of Agriculture & Rural Development (MDARD) Laboratory Division revealed the presence of Listeria monocytogenes." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall, the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall," the FDA continued. It added: "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled mushrooms may return the product to the original place of purchase for a full refund or destroy it, the FDA says. People with additional questions may contact the company at (917) 756-9833 weekdays from 9 a.m. to 2 p.m.